Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread

NCT02658890

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations
  • Local Institution - 0028 Tucson, Arizona, United States
  • Local Institution - 0026 La Jolla, California, United States
  • Local Institution - 0035 Tampa, Florida, United States
  • Local Institution - 0005 Atlanta, Georgia, United States
View all 47 locations
View Trial Details
Completed

Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma

NCT01152788

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
View all 19 locations
View Trial Details
Completed

Efficacy Study of IL-21 to Treat Metastatic Melanoma

NCT00336986

Conditions
Cancer, Malignant Melanoma, Melanoma, +11 more
Locations
  • Novo Nordisk Investigational Site Box Hill, Australia
  • Novo Nordisk Investigational Site East Melbourne, Australia
  • Novo Nordisk Investigational Site Heidelberg, Australia
  • Novo Nordisk Investigational Site Malvern, Australia
View Trial Details
Completed

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

NCT00053781

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada
  • Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada
  • Princess Margaret Hospital at University Health Network Toronto, Ontario, Canada
View Trial Details
Completed

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

NCT00514085

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View Trial Details

Related conditions